The intricate, data-heavy world of drug development is getting an AI-native overhaul, thanks to Cheiron, which has just closed an $8.0M seed funding round. The startup is building an operating system designed to unify scientific, clinical, regulatory, and competitive workflows for biopharma teams.
Cheiron's platform integrates vast amounts of information, from literature to clinical trials and patents, into a single Lifesciences Knowledge Graph. On this structured foundation, AI agents generate decision-ready outputs, grounded in cross-domain evidence and built for real-world execution.

.png&w=3840&q=75)











